Mills-Peninsula Health Services, San Mateo, California 94401, USA.
J Clin Endocrinol Metab. 2011 Oct;96(10):2968-79. doi: 10.1210/jc.2010-2756.
The aim was to formulate practice guidelines for determining settings where patients are most likely to benefit from the use of continuous glucose monitoring (CGM).
The Endocrine Society appointed a Task Force of experts, a methodologist, and a medical writer.
This evidence-based guideline was developed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to describe both the strength of recommendations and the quality of evidence.
One group meeting, several conference calls, and e-mail communications enabled consensus. Committees and members of The Endocrine Society, the Diabetes Technology Society, and the European Society of Endocrinology reviewed and commented on preliminary drafts of these guidelines.
The Task Force evaluated three potential uses of CGM: 1) real-time CGM in adult hospital settings; 2) real-time CGM in children and adolescent outpatients; and 3) real-time CGM in adult outpatients. The Task Force used the best available data to develop evidence-based recommendations about where CGM can be beneficial in maintaining target levels of glycemia and limiting the risk of hypoglycemia. Both strength of recommendations and quality of evidence were accounted for in the guidelines.
制定确定患者最有可能从连续血糖监测（CGM）中获益的应用环境的实践指南。
内分泌学会任命了一个专家工作组、一名方法学家和一名医学撰稿人。
本循证指南采用推荐分级、评估、制定与评价（GRADE）系统制定，用于描述建议的强度和证据质量。
一次小组会议、多次电话会议和电子邮件通信促成了共识。内分泌学会、糖尿病技术学会和欧洲内分泌学会的委员会和成员审查并评论了这些指南的初步草案。
工作组评估了 CGM 的三种潜在用途：1）成人住院环境中的实时 CGM；2）儿童和青少年门诊患者中的实时 CGM；3）成人门诊患者中的实时 CGM。工作组利用现有最佳数据制定了关于 CGM 在维持血糖目标水平和降低低血糖风险方面有益的循证建议。指南中考虑了建议的强度和证据的质量。
